Stockreport

Lantheus Continues to Commend CMS’ CY25 Rule to Enhance Payment for Specialized Diagnostic Radiopharmaceuticals and Reaffirms Outlook for PYLARIFY’s Blockbuster Status for 2025

Lantheus Holdings, Inc.  (LNTH) 
Last lantheus holdings, inc. earnings: 2/25 07:00 am Check Earnings Report
US:NASDAQ Investor Relations: investor.lantheus.com/investor-relations
PDF BEDFORD, Mass., Nov. 11, 2024 (GLOBE NEWSWIRE) -- Lantheus Holdings, Inc. (“Lantheus” or the “Company”) (NASDAQ: LNTH), the leading radiopharmaceutical-focused company [Read more]